ITGAX and myasthenia gravis: In rituximab-naïve MuSK-MG, we observed strong positive correlations between T-bet (r = 0.74, p = 0.0058) and CD20 (r = 0.63, p = 0.028) expression in CD11c+ B cells and antibody levels (Figure 7C).